Cargando…

The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis

BACKGROUND: Dextrose prolotherapy (DPT) is considered to be a type of regenerative therapy and is widely used in various musculoskeletal disorders. Plantar fasciitis is a common cause of heel pain that affects the quality of life of many people. We aimed to evaluate the effectiveness and safety of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Wei-Fu, Yoon, Chang Ho, Chiang, Meng Ting, Hong, Ying-Han, Chen, Hui-Chuan, Song, Wenyu, Chin, Yen Po (Harvey)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702280/
https://www.ncbi.nlm.nih.gov/pubmed/34941081
http://dx.doi.org/10.1097/MD.0000000000028216
_version_ 1784621210585268224
author Lai, Wei-Fu
Yoon, Chang Ho
Chiang, Meng Ting
Hong, Ying-Han
Chen, Hui-Chuan
Song, Wenyu
Chin, Yen Po (Harvey)
author_facet Lai, Wei-Fu
Yoon, Chang Ho
Chiang, Meng Ting
Hong, Ying-Han
Chen, Hui-Chuan
Song, Wenyu
Chin, Yen Po (Harvey)
author_sort Lai, Wei-Fu
collection PubMed
description BACKGROUND: Dextrose prolotherapy (DPT) is considered to be a type of regenerative therapy and is widely used in various musculoskeletal disorders. Plantar fasciitis is a common cause of heel pain that affects the quality of life of many people. We aimed to evaluate the effectiveness and safety of DPT for plantar fasciitis. METHODS: PubMed, Embase, and the Cochrane Library were searched from their respective inception dates to June 2021. Only randomized controlled trials comparing DPT and other interventions for plantar fasciitis were included in this review. Standardized mean differences (SMDs) with 95% confidence intervals were calculated for comparison. The outcome measurements included visual analog score, numeric rating scale, Foot Function index, Revised Foot Function index, American Orthopedic Foot and Ankle Score, and plantar fascia thickness. Post-treatment duration was classified as short-term (1–2 months), medium-term (3 months), or long-term (6 months). RESULTS: Six studies with 388 adult patients diagnosed with plantar fasciitis were included for the meta-analysis. In terms of pain scores improvement, DPT was superior to placebo or exercise in the short-term (SMD: −1.163, 95%CI: −2.17 to −0.156) and the medium-term (SMD: −1.394, 95%CI: −2.702 to −0.085). DPT was inferior to corticosteroid injection in the short-term (SMD: 0.781, 95%CI: 0.41 to 1.152). For functional improvement, DPT was superior to placebo or exercise in the short-term (SMD: −1.51, 95%CI: −2.96 to −0.059), but inferior to corticosteroid injection (SMD: 0.526, 95%CI: 0.161 to 0.89) and extracorporeal shock wave therapy in the short-term (SMD: 0.484, 95%CI: 0.145 to 0.822). Randomized controlled trials showed a better pain improvement in the long-term for patients treated with DPT compared to corticosteroid (P = .002) and exercise control (P < .05). No significant differences were found between patients treated with DPT and patients treated with platelet-rich plasma. CONCLUSION: Dextrose prolotherapy was a safe and effective treatment option for plantar fasciitis that may have long-term benefits for patients. The effects were comparable to extracorporeal shock wave therapy or platelet-rich plasma injection. Further studies with standardized protocols and long-term follow-up are needed to address potential biases.
format Online
Article
Text
id pubmed-8702280
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-87022802021-12-27 The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis Lai, Wei-Fu Yoon, Chang Ho Chiang, Meng Ting Hong, Ying-Han Chen, Hui-Chuan Song, Wenyu Chin, Yen Po (Harvey) Medicine (Baltimore) 7000 BACKGROUND: Dextrose prolotherapy (DPT) is considered to be a type of regenerative therapy and is widely used in various musculoskeletal disorders. Plantar fasciitis is a common cause of heel pain that affects the quality of life of many people. We aimed to evaluate the effectiveness and safety of DPT for plantar fasciitis. METHODS: PubMed, Embase, and the Cochrane Library were searched from their respective inception dates to June 2021. Only randomized controlled trials comparing DPT and other interventions for plantar fasciitis were included in this review. Standardized mean differences (SMDs) with 95% confidence intervals were calculated for comparison. The outcome measurements included visual analog score, numeric rating scale, Foot Function index, Revised Foot Function index, American Orthopedic Foot and Ankle Score, and plantar fascia thickness. Post-treatment duration was classified as short-term (1–2 months), medium-term (3 months), or long-term (6 months). RESULTS: Six studies with 388 adult patients diagnosed with plantar fasciitis were included for the meta-analysis. In terms of pain scores improvement, DPT was superior to placebo or exercise in the short-term (SMD: −1.163, 95%CI: −2.17 to −0.156) and the medium-term (SMD: −1.394, 95%CI: −2.702 to −0.085). DPT was inferior to corticosteroid injection in the short-term (SMD: 0.781, 95%CI: 0.41 to 1.152). For functional improvement, DPT was superior to placebo or exercise in the short-term (SMD: −1.51, 95%CI: −2.96 to −0.059), but inferior to corticosteroid injection (SMD: 0.526, 95%CI: 0.161 to 0.89) and extracorporeal shock wave therapy in the short-term (SMD: 0.484, 95%CI: 0.145 to 0.822). Randomized controlled trials showed a better pain improvement in the long-term for patients treated with DPT compared to corticosteroid (P = .002) and exercise control (P < .05). No significant differences were found between patients treated with DPT and patients treated with platelet-rich plasma. CONCLUSION: Dextrose prolotherapy was a safe and effective treatment option for plantar fasciitis that may have long-term benefits for patients. The effects were comparable to extracorporeal shock wave therapy or platelet-rich plasma injection. Further studies with standardized protocols and long-term follow-up are needed to address potential biases. Lippincott Williams & Wilkins 2021-12-23 /pmc/articles/PMC8702280/ /pubmed/34941081 http://dx.doi.org/10.1097/MD.0000000000028216 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 7000
Lai, Wei-Fu
Yoon, Chang Ho
Chiang, Meng Ting
Hong, Ying-Han
Chen, Hui-Chuan
Song, Wenyu
Chin, Yen Po (Harvey)
The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis
title The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis
title_full The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis
title_fullStr The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis
title_full_unstemmed The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis
title_short The effectiveness of dextrose prolotherapy in plantar fasciitis: A systemic review and meta-analysis
title_sort effectiveness of dextrose prolotherapy in plantar fasciitis: a systemic review and meta-analysis
topic 7000
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702280/
https://www.ncbi.nlm.nih.gov/pubmed/34941081
http://dx.doi.org/10.1097/MD.0000000000028216
work_keys_str_mv AT laiweifu theeffectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT yoonchangho theeffectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT chiangmengting theeffectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT hongyinghan theeffectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT chenhuichuan theeffectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT songwenyu theeffectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT chinyenpoharvey theeffectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT laiweifu effectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT yoonchangho effectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT chiangmengting effectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT hongyinghan effectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT chenhuichuan effectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT songwenyu effectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis
AT chinyenpoharvey effectivenessofdextroseprolotherapyinplantarfasciitisasystemicreviewandmetaanalysis